John Gordon
Interventional Cardiology · San Diego, CANPI 1962483099
Payments from drug & device makers
Across 264 payments — averaging $155.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$34K
- W. L. Gore & Associates, Inc.$1K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Amgen$622
- Shockwave Medical, Inc$480
- Medtronic$450
- plus $3K from 29 others
What the payments were for
- Food & beverage$9,602100%
- Education$220%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 61 | $34,425 |
| W. L. Gore & Associates, Inc. | 18 | $1,114 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 65 | $1,092 |
| Amgen | 11 | $622 |
| Shockwave Medical, Inc | 4 | $480 |
| Medtronic(2 entities) | 6 | $450 |
| Boston Scientific | 11 | $317 |
| Johnson & Johnson | 14 | $313 |
| Cathworks, Inc. | 4 | $293 |
| Novartis | 19 | $279 |
| Cvrx, Inc. | 4 | $196 |
| E.r. Squibb & Sons, L.L.C. | 5 | $161 |
| Esperion Therapeutics, Inc. | 3 | $158 |
| Philips North America LLC | 1 | $123 |
| Terumo Medical Corporation | 2 | $115 |
| Bayer | 2 | $114 |
| Heartflow, Inc. | 3 | $113 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $101 |
| AstraZeneca | 5 | $64 |
| GE HealthCare | 1 | $60 |
| Alnylam Pharmaceuticals Inc. | 3 | $49 |
| Baxter Healthcare | 1 | $47 |
| Pfizer | 2 | $35 |
| CSL Behring | 1 | $30 |
| Bardy Diagnostics, Inc. | 2 | $27 |
| Akcea Therapeutics, Inc. | 1 | $26 |
| Irhythm Technologies, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $23 |
| Tactile Systems Technology Inc | 2 | $23 |
| Biosense Webster, Inc. | 1 | $23 |
| Biotronik Inc. | 1 | $22 |
| United Therapeutics Corporation | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 5 | $18 |
| Sobi, Inc | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Xience Sierra Coronary Stent$734
- Repatha$367
- Quadra Assura CRT Defibrillator$353
- Xience Sierra Coronary Stent System$347
- GORE EXCLUDER AAA Endoprosthesis$312
- AVEIR$306
- Xience Alpine cornary stent system$260
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$220
- Vascular Lithotripsy$178
- XIENCE SIERRA$155
- FFRangio System$152
- XIENCE SKYPOINT$148
- CoreValve Evolut$144
- Resolute$127
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$127
- CT Equip Undiv$123
- GORE TAG Thoracic Endoprosthesis$119
- CAMZYOS$119
- XARELTO$118
- NEXLIZET$117
How this compares
$40,981 in reported general payments places this provider in the 75th percentile of 585 interventional cardiology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ezetimibe | 32 | $514 |
| Valsartan | 12 | $443 |
| Atorvastatin Calcium | 28 | $197 |
| Metoprolol Succinate | 13 | $143 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in San Diego
- Ehtisham MahmudSan Diego$1.5M
- Mitul PatelSan Diego$852K
- Raghava GollapudiSan Diego$842K
- Lawrence AngSan Diego$384K
- Jeffrey CavendishSan Diego$355K
- Luke OakleySan Diego$317K
- Justin CoxSan Diego$291K
- Arvin NarulaSan Diego$285K
- Rajendra MakkarWest Hollywood$16.6M
- Fahed BitarCovina$9.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.